Cargando…
Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
BACKGROUND: Central to the pathogenesis of Alzheimer’s disease (AD) and many other neurodegenerative diseases is the conformational change of a normal self-protein into toxic oligomeric species and amyloid deposits. None of these disorders have an effective therapy, but immunization approaches hold...
Autores principales: | Goñi, Fernando, Herline, Krystal, Peyser, Daniel, Wong, Kinlung, Ji, Yong, Sun, Yanjie, Mehta, Pankaj, Wisniewski, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878790/ https://www.ncbi.nlm.nih.gov/pubmed/24330773 http://dx.doi.org/10.1186/1742-2094-10-150 |
Ejemplares similares
-
Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice
por: Abdallah, Ihab M., et al.
Publicado: (2021) -
Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases
por: Goñi, Fernando, et al.
Publicado: (2017) -
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
por: Goñi, Fernando, et al.
Publicado: (2018) -
Oleocanthal Enhances Amyloid-β Clearance
from the Brains of TgSwDI Mice and in Vitro across a Human Blood-Brain
Barrier Model
por: Qosa, Hisham, et al.
Publicado: (2015) -
Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice
por: Van der Jeugd, Ann, et al.
Publicado: (2018)